flavonoid
dietari
compon
ubiquit
phenol
compound
found
natur
show
rang
pharmacolog
activ
includ
antivir
action
studi
describ
antivir
screen
differ
flavon
flavonol
human
rotaviru
strain
well
cytotox
cell
cytotox
investig
cell
morpholog
assess
antirotaviru
activ
cytopath
effect
inhibit
result
express
cc
ic
respect
order
calcul
select
index
si
cc
ic
compound
structureact
relationship
sar
propos
base
antirotaviru
activ
flavonoid
polyphenol
compound
found
dietari
compon
food
product
beverag
herbal
medicin
differ
health
benefit
shown
larg
number
studi
sever
pharmacolog
activ
describ
flavonoid
antitumor
antibacteri
antifung
antiallerg
estrogen
antiinflammatori
prevent
cardiovascular
diseas
antivir
addit
wellknown
antioxid
metal
ionchel
natur
product
shown
import
sourc
use
compound
antivir
chemotherapi
compound
promis
activ
use
directli
drug
lead
synthesi
new
drug
last
year
effort
made
increas
number
compound
antivir
activ
clinic
use
current
avail
antivir
drug
use
restrict
narrow
spectrum
activ
limit
therapeut
use
variabl
degre
toxic
furthermor
therapeut
potenc
antivir
agent
encount
far
counterbalanc
sever
side
effect
human
case
efficaci
drug
limit
increas
viral
resist
therefor
search
antivir
compound
high
efficaci
low
toxic
minor
side
effect
must
continu
improv
drug
therapi
flavonoid
investig
antivir
activ
instanc
human
cytomegaloviru
herp
simplex
viru
type
influenza
viru
respiratori
synciti
viru
adenoviru
varicella
zoster
viru
polioviru
rhinoviru
sindbi
viru
coronaviru
parainfluenzaviru
coxsackieviru
b
hiv
rotaviru
among
enter
virus
rotavirus
major
caus
sever
diarrhea
believ
would
account
pediatr
hospit
acut
gastroenter
rotavirus
affect
nearli
popul
regardless
level
hygien
qualiti
water
food
sanit
gener
estim
incid
rotavirus
develop
develop
countri
similar
infect
may
asymptomat
may
present
mild
vomit
andor
diarrhea
also
caus
sever
diseas
lead
potenti
fatal
dehydr
current
goal
treatment
rotavirus
gastroenter
prevent
treat
dehydr
prevent
nutrit
damag
diarrhea
episod
recent
two
rotaviru
vaccin
enter
market
rotarix
glaxosmithklin
rotateq
merckcsl
sever
issu
could
resolv
new
vaccin
rotaviru
nonenvelop
viru
segment
doublestrand
rna
genom
surround
three
concentr
protein
layer
accord
coulson
liakato
et
al
rotaviru
entri
host
cell
multistep
process
requir
least
three
viru
hostcel
interact
rotaviru
initi
bind
host
cellsurfac
glycoconjug
follow
interact
independ
sialic
acid
believ
part
lipid
domain
integrin
thought
play
import
role
understand
interact
mechan
viru
cell
relev
sinc
contribut
ration
select
compound
test
antivir
assay
import
health
public
problem
signific
amount
data
avail
rotaviru
replic
well
promis
biolog
effect
flavonoid
led
us
use
viru
system
studi
antivir
activ
differ
compound
thu
aim
studi
evalu
potenti
antirotaviru
flavonol
flavon
fig
tabl
investig
structureact
relationship
sar
flavonol
identifi
purchas
sigma
other
synthes
flavon
identifi
synthes
other
purchas
sigma
compound
assay
toxic
cell
microscop
morpholog
evalu
antirotaviru
activ
strain
cytopathogen
inhibit
dissolv
dimethyl
sulfoxid
dmso
merck
darmstadt
germani
dilut
medium
sigma
chemic
co
st
loui
mo
usa
filter
membran
millipor
bedfor
usa
stock
solut
store
protect
light
use
use
cell
line
cell
biolog
scienc
institut
univers
paulo
brazil
grown
medium
sigma
chemic
co
st
loui
mo
usa
supplement
fetal
bovin
serum
gibco
brl
new
york
usa
penicillin
g
uml
streptomycin
amphotericin
b
gibco
brl
new
york
usa
cell
cultur
maintain
humidifi
co
atmospher
human
rotaviru
atcc
use
propag
cell
presenc
trypsin
sigma
stock
virus
prepar
previous
describ
barardi
et
al
supernat
fluid
harvest
titrat
store
use
viru
titer
estim
cytopathogen
limitdilut
method
express
tissu
cultur
infecti
dose
per
ml
tcid
ml
cc
cytotox
concentr
cell
ic
inhibitori
concentr
infect
cell
valu
estim
concentrationeffect
curv
linear
regress
analysi
repres
mean
valu
three
independ
experi
select
index
si
cc
ic
calcul
test
flavonoid
accord
sidwel
si
promis
antivir
activ
must
consid
select
index
si
calcul
cytotox
inhibitor
concentr
tabl
present
studi
cytotox
antivir
action
flavonoid
evalu
cell
suscept
human
rotaviru
take
account
result
select
index
compound
calcul
valu
consid
describ
sar
test
flavonoid
divid
group
accord
similar
structur
characterist
sar
propos
consid
conform
effect
exert
substitu
flavonol
ring
without
radic
compound
hydroxyl
group
orto
posit
grant
antivir
activ
meta
posit
consid
one
methoxyl
b
ring
antivir
action
observ
contrast
exist
two
three
methoxyl
radic
b
ring
consider
antirotaviru
action
detect
presenc
benzyloxyl
radic
ring
view
ethoxyl
radic
b
ring
promis
antivir
activ
link
presenc
two
radic
meta
posit
compound
butoxyl
radic
b
ring
also
show
activ
higher
activ
ortometa
posit
radic
antivir
activ
provid
compound
one
butoxyl
group
ring
one
ethyl
radic
b
ring
one
benzyloxyl
radic
simultan
b
ring
ring
one
methoxyl
group
antivir
activ
detect
b
ring
also
methoxyl
posit
one
substitu
ethoxyl
ring
antivir
activ
detect
presenc
one
ethoxyl
radic
b
ring
posit
view
b
ring
contain
two
hydroxyl
group
one
antivir
activ
observ
result
observ
flavonol
compris
one
hydroxyl
b
ring
substitu
ring
flavonol
presenc
two
methoxyl
ethoxyl
radic
one
two
butoxyl
radic
one
benzyloxyl
radic
show
antivir
activ
compound
contain
one
methoxyl
ethoxyl
radic
reduc
rotaviru
infect
view
role
sialic
acid
infect
rotaviru
fazli
et
al
evalu
antivir
effect
lactosebas
sialylmimet
differ
chemic
variat
order
find
new
target
therapeut
intervent
result
studi
suggest
small
alkyl
group
toler
bind
pocket
viral
adhes
protein
bovin
human
strain
aryl
group
may
steric
demand
hydrophob
human
wa
strain
rotaviru
find
could
contribut
explain
higher
antirotaviru
effect
found
flavonol
butoxyl
group
one
benzyloxyl
radic
compound
highest
select
index
test
compound
concern
test
flavon
antivir
action
shown
b
c
ring
methoxyl
substitu
one
hydroxyl
hydroxyl
radic
ring
case
flavon
without
methoxyl
substitu
b
ring
presenc
orhamnos
orhamnoglucos
posit
respect
absenc
radic
c
ring
provid
antivir
activ
bae
et
al
test
vitro
inhibitori
action
differ
rhamnoglycosid
rotaviru
infect
dosmin
hesperidin
higher
activ
ic
author
report
low
inhibitori
effect
rutin
could
relat
low
solubl
water
antirotaviru
activ
result
found
studi
compound
rutin
quercetrin
similar
bae
et
al
hand
jolli
et
al
consid
galactos
import
compon
host
cell
receptor
sinc
appli
galectin
galactoserecognis
protein
inhibit
rotaviru
infect
howev
flavonoid
contain
sugar
synthes
studi
order
evalu
antirotaviru
effect
presenc
oso
radic
methoxyl
radic
c
ring
confer
antivir
activ
takahashi
et
al
evalu
vitro
vivo
antivir
activ
sulfat
sialyl
lipid
suggest
compound
may
bind
specif
site
andor
human
rotaviru
either
hydrophob
associ
lipid
chain
neg
charg
sulfat
residu
follow
interfer
bind
andor
cellular
receptor
steric
hindranc
although
one
compound
contain
oso
radic
test
studi
group
appear
import
antivir
effect
take
consider
one
methoxyl
radic
radic
c
ring
presenc
methoxyl
radic
ring
provid
antivir
activ
independ
hydroxyl
group
ring
howev
antivir
activ
shown
presenc
absenc
benzyloxyl
methoxyl
radic
ring
respect
presenc
two
methoxyl
radic
b
ring
radic
c
ring
addit
methoxyl
radic
ring
contribut
antivir
activ
independ
hydroxyl
group
last
ring
hand
antivir
effect
shown
presenc
four
methoxyl
substitu
b
ring
two
methoxyl
radic
b
ring
one
methoxyl
c
ring
weak
antirotaviru
activ
verifi
flavon
similar
characterist
b
c
ring
distinguish
test
flavon
methoxyl
hydroxyl
radic
b
ring
absenc
methoxyl
posit
ring
could
explain
antivir
activ
compound
compar
consid
c
ring
absenc
methoxyl
posit
b
ring
could
explain
antivir
activ
observ
test
flavon
sar
analysi
suggest
presenc
methoxyl
group
ring
relev
antirotaviru
action
nevertheless
characterist
ring
also
need
consid
compound
thirtyfour
amongst
test
compound
show
moder
antivir
activ
si
result
encourag
explor
properti
flavonoid
well
confirm
detect
antirotaviru
activ
methodolog
investig
action
mechan
effect
vitro
structur
aspect
repres
preliminari
result
sinc
antivir
cytotox
activ
flavonoid
relat
multipl
factor
concomitantli
metabol
studi
carri
due
fact
sever
flavonoid
degrad
variabl
extent
digest
tabl
substitut
pattern
test
flavon
cytotox
cc
viral
inhibitori
ec
concentr
well
select
indic
si
cc
ic
tract
screen
bioactiv
compound
synthet
isol
natur
sourc
evalu
sar
alli
technolog
advanc
requir
develop
effect
safer
new
drug
alreadi
avail
